About the Study The present study aimed to address this persistent knowledge gap by analyzing data from the Medical Expenditure Panel Survey (MEPS) to investigate how usage patterns and associated payments differed across GLP-1RA types and by diabetes status, and to inform policies intended to reduce total and out-of-pocket GLP-1RA payments
The compounded GLP-1 medications it connects patients with - semaglutide starting at $199/month and tirzepatide starting at $349/month - are priced well below FDA-approved branded alternatives, with the tradeoffs that compounded medications carry: no FDA premarket review as finished products, and an active regulatory environment that could change their availability
Despite the growing concerns and reports of side effects, including gastrointestinal issues, pancreas inflammation, and gallbladder problems, the drugs continue to be widely used for weight loss
Our Commitment to Your Health and Safety Our brand personality is built on being empathetic, innovative, trustworthy, supportive, results-oriented, and profoundly personalized
HSA and FSA cards are accepted for both compounded and branded plans at checkout
Some patients plateau
